Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (381-390 of 405) with videos related to

Pageof 41
Sort By:
Biorxiv : the Preprint Server for Biology|March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primatesJuan I Moliva, Shayne F Andrew, Barbara J Flynn, et al.
Nature Medicine|October 7, 2016
Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionMonica Vaccari, Shari N Gordon, Slim Fourati, et al.
Cell|December 18, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lungMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman PrimatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Nature Medicine|May 31, 2016
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionMonica Vaccari, Shari N Gordon, Slim Fourati, et al.
Science Immunology|August 30, 2024
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding siteTom G Caniels, Max Medina-Ramìrez, Shiyu Zhang, et al.
Iscience|February 8, 2021
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidatesIsabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, et al.
Science (New York, N.Y.)|December 1, 2022
Vaccination induces HIV broadly neutralizing antibody precursors in humansDavid J Leggat, Kristen W Cohen, Jordan R Willis, et al.
Nature Immunology|August 21, 2021
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Pageof 41

Showing results (381-390 of 405) with videos related to

Sort By:
Pageof 41
Biorxiv : the Preprint Server for Biology|March 3, 2021
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variantsLingshu Wang, Tongqing Zhou, Yi Zhang, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primatesJuan I Moliva, Shayne F Andrew, Barbara J Flynn, et al.
Nature Medicine|October 7, 2016
Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionMonica Vaccari, Shari N Gordon, Slim Fourati, et al.
Cell|December 18, 2021
Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lungMatthew Gagne, Kizzmekia S Corbett, Barbara J Flynn, et al.
Biorxiv : the Preprint Server for Biology|June 2, 2021
Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman PrimatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Nature Medicine|May 31, 2016
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisitionMonica Vaccari, Shari N Gordon, Slim Fourati, et al.
Science Immunology|August 30, 2024
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding siteTom G Caniels, Max Medina-Ramìrez, Shiyu Zhang, et al.
Iscience|February 8, 2021
Anti-V2 antibodies virus vulnerability revealed by envelope V1 deletion in HIV vaccine candidatesIsabela Silva de Castro, Giacomo Gorini, Rosemarie Mason, et al.
Science (New York, N.Y.)|December 1, 2022
Vaccination induces HIV broadly neutralizing antibody precursors in humansDavid J Leggat, Kristen W Cohen, Jordan R Willis, et al.
Nature Immunology|August 21, 2021
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primatesKizzmekia S Corbett, Anne P Werner, Sarah O' Connell, et al.
Pageof 41